With the revolutionary Ori manufacturing platform, it will be possible to increase throughput, improve quality and decrease costs in Cell and Gene Therapy (CGT) manufacturing, so that more patients can experience life's most precious moments with the people they love.
Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.
By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.
So complex manufacturing challenges can be put where they belong – in the past.
Ori is pioneering the future of CGT manufacturing technology, bringing together the most innovative minds in the field who are truly passionate about helping to manufacture brighter futures.
Co-Founder and Chief Scientific Officer
Chief Executive Officer and Executive Director
Chief Business Officer
Chief Digital Officer
Chief Technology Officer
Head of Process Development
Head of Cell Processing
Global Finance Director
Scientific Project Manager
VP Commercial Operations
VP Technical Operations
Discover how we're driving innovation in CGT manufacturing.